STOCK TITAN
  1. Home
  2. Sec-filings
  3. NUVL
  4. [Form 4] Nuvalent, Inc. Insider Trading Activity

Nuvalent (NUVL) CFO Balcom sells 11,430 shares and exercises options under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nuvalent, Inc. Chief Financial Officer Alexandra Balcom reported a mix of stock sales and an option exercise in Class A Common Stock. On June 1, 2026, she sold a total of 11,430 shares in multiple open-market transactions at weighted average prices within ranges from $94.48 to $104.19 per share under a pre-arranged Rule 10b5-1 trading plan adopted on December 23, 2025.

On the same date, she exercised stock options to acquire 11,430 shares at an exercise price of $6.89 per share. Following these transactions, Balcom directly owned 96,963 shares of Nuvalent Class A Common Stock, indicating she retained a substantial equity position after the activity.

Positive

  • None.

Negative

  • None.

Insights

CFO Balcom executed pre-planned sales and an option exercise while retaining a sizable stake.

Nuvalent’s Chief Financial Officer Alexandra Balcom conducted routine insider activity involving both an option exercise and open-market sales of Class A Common Stock. She exercised stock options for 11,430 shares at an exercise price of $6.89 per share, converting derivative compensation into common equity.

She also sold 11,430 shares in several open-market trades at weighted average prices within ranges from $94.48 to $104.19, pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025. Such plans are established in advance and are designed to make trading more systematic.

After these transactions, Balcom directly owned 96,963 shares of Nuvalent Class A Common Stock. The filing shows eight sale transactions and one option exercise on June 1, 2026, suggesting ongoing portfolio management rather than a full exit of her position.

Insider Balcom Alexandra
Role Chief Financial Officer
Sold 11,430 shs ($1.13M)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 11,430 $0.00 --
Exercise Class A Common Stock 11,430 $6.89 $79K
Sale Class A Common Stock 960 $94.87 $91K
Sale Class A Common Stock 2,170 $95.99 $208K
Sale Class A Common Stock 900 $97.68 $88K
Sale Class A Common Stock 1,200 $98.57 $118K
Sale Class A Common Stock 3,133 $99.86 $313K
Sale Class A Common Stock 2,588 $100.65 $260K
Sale Class A Common Stock 279 $101.79 $28K
Sale Class A Common Stock 200 $103.84 $21K
Holdings After Transaction: Stock Option (Right to Buy) — 13,400 shares (Direct, null); Class A Common Stock — 96,963 shares (Direct, null)
Footnotes (1)
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.48 to $95.40, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) of this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.51 to $96.45, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.00 to $97.98, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.10 to $99.08, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.33 to $100.32, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.33 to $101.29, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.44 to $102.37, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.49 to $104.19, inclusive. The shares underlying this option are fully vested.
Shares sold 11,430 shares Total Class A Common Stock sold in open-market transactions on June 1, 2026
Sale price ranges $94.48–$104.19 per share Weighted average price ranges across multiple sale transactions
Options exercised 11,430 shares at $6.89/share Stock option exercise into Class A Common Stock on June 1, 2026
Shares owned after 96,963 shares Direct Class A Common Stock holdings following reported transactions
Sale transactions count 8 transactions Number of open-market sale entries reported for Class A Common Stock
Net buy/sell shares -11,430 shares Net share change from combined sales and acquisitions in transaction summary
Rule 10b5-1 trading plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.48 to $95.40, inclusive."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Class A Common Stock financial
"security_title": "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Balcom Alexandra
(Last)(First)(Middle)
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR
(Street)
CAMBRIDGE MASSACHUSETTS 02142
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/01/2026M(1)11,430A$6.8996,963D
Class A Common Stock06/01/2026S(1)960D$94.87(2)96,003D
Class A Common Stock06/01/2026S(1)2,170D$95.99(3)93,833D
Class A Common Stock06/01/2026S(1)900D$97.68(4)92,933D
Class A Common Stock06/01/2026S(1)1,200D$98.57(5)91,733D
Class A Common Stock06/01/2026S(1)3,133D$99.86(6)88,600D
Class A Common Stock06/01/2026S(1)2,588D$100.65(7)86,012D
Class A Common Stock06/01/2026S(1)279D$101.79(8)85,733D
Class A Common Stock06/01/2026S(1)200D$103.84(9)85,533D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$6.8906/01/2026M(1)11,430 (10)04/29/2031Class A Common Stock11,430$0.0013,400D
Explanation of Responses:
1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.48 to $95.40, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) of this Form 4.
3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.51 to $96.45, inclusive.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.00 to $97.98, inclusive.
5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.10 to $99.08, inclusive.
6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.33 to $100.32, inclusive.
7. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.33 to $101.29, inclusive.
8. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.44 to $102.37, inclusive.
9. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.49 to $104.19, inclusive.
10. The shares underlying this option are fully vested.
/s/ Nathan N. McConarty, attorney-in-fact06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR